Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F72CA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,350
Award facts
- Contract value 100% obligated
- $34,350.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injectables with a ceiling value of $34,350.42. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of November 13, 2025. The contract is executed as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor. The company demonstrates significant capability in fulfilling federal medical supply requirements through its extensive portfolio of pharmaceutical deliveries with the Defense Logistics Agency and Medical Supply Chain, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The delivery of Zepbound, a diabetes medication, aligns with the company's established track record in supplying specialized pharmaceutical products to support military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F72CA?
SPE2DR26F72CA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F72CA worth?
The government has obligated $34,350 on SPE2DR26F72CA.
Is contract SPE2DR26F72CA an order under another contract?
Yes. SPE2DR26F72CA is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F72CA competed?
The extent of competition for SPE2DR26F72CA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award